argenx SE announced that at the Annual General Meeting of shareholders held on May 7, 2024 Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the Board, supporting the Company?s innovation mission across therapeutic areas.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
339.9 EUR | -1.45% | -2.30% | -1.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.05% | 21.96B | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B | |
-24.95% | 8.23B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors